Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine to prevent postoperative delirium after craniotomy
ChiCTR2100044658Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative delirium (POD) comparing Dexmedetomidine group with Control (saline placebo) group (2 arms). Primary endpoint: Postoperative delirium. Started Apr 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100044658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044658.